Oral anticoagulant treatment with and without aspirin

Area of Science:

• Cardiology
• Pharmacology
• Vascular Medicine

Background:

• Thromboembolic events pose significant risks in various cardiovascular conditions.
• Concurrent oral anticoagulant and antiplatelet therapy is a proposed strategy for prevention.
• Existing evidence supports this combination in specific contexts like prosthetic heart valves.

Purpose of the Study:

• To evaluate the efficacy of moderate intensity anticoagulation plus aspirin in preventing thromboembolic events.
• To explore the potential benefits of this regimen in arterial diseases beyond prosthetic heart valves.
• To assess the applicability of findings from prosthetic heart valve patients to conditions like unstable angina and ischemic heart disease.

Main Methods:

• Utilizing moderate intensity anticoagulants targeting an International Normalized Ratio (INR) of 2-3.
• Administering aspirin at a dosage of 100 mg/day concurrently with anticoagulants.
• Analyzing data from studies involving prosthetic heart valves and trials like ATACS in unstable angina.

Main Results:

• Moderate intensity anticoagulation with aspirin significantly decreases the incidence and severity of embolic episodes in prosthetic heart valve patients.
• The ATACS trial suggests potential benefits for this regimen in preventing thrombotic events in unstable angina.

Conclusions:

• The combination of moderate intensity anticoagulation and aspirin is effective for preventing thromboembolic events in prosthetic heart valves.
• Further research, including ongoing studies in ischemic heart diseases, is needed to confirm the broader applicability of this therapeutic strategy in other arterial diseases.